drugset / Trial / NCT07649941
A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of a moderate CYP 3A inducer bosentan on the pharmacokinetics of zongertinib.
Timeline
- Start
- 2026-06-22
- Primary completion
- 2026-07-31
- Completion
- 2026-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bosentan | Other / unclassified | — | — |
| Subject | Zongertinib | Small molecule | — | — |
Indications
No indication recorded.